Emergence of quinolone-resistant Shigella flexneri in Italy (March 2017)

Int J STD AIDS. 2018 Nov;29(11):1123-1126. doi: 10.1177/0956462418769805. Epub 2018 May 10.

Abstract

In March 2017, a 45-year-old Italian man who has sex with men was admitted to the Infectious Diseases Department of Trieste Hospital (northeast Italy), because of fever, abdominal pain and dysentery. The patient had neither foreign travel history nor sexual contact with non-Italian partners. Stool cultures grew multidrug-resistant Shigella flexneri (resistant to ampicillin, chloramphenicol, streptomycin, tetracycline, trimethoprim, amoxicillin/clavulanic acid and ciprofloxacin) and whole genome sequencing detailed the resistance features. The phylogenetic analysis showed that the strain was unrelated to any previously reported strain. The patient was treated successfully with ceftriaxone. We hereby report the first case of locally-acquired, multidrug-resistant S. flexneri infection in Italy and also the emergence of a new clone.

Keywords: Epidemiology; Shigella; antibiotic resistance; bacterial disease; uinolone resistance.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Ceftriaxone / pharmacology*
  • Ceftriaxone / therapeutic use
  • Drug Resistance, Multiple, Bacterial / genetics*
  • Dysentery, Bacillary / drug therapy*
  • Dysentery, Bacillary / microbiology
  • Feces / microbiology
  • Genes, Bacterial / genetics
  • Genome, Bacterial
  • Homosexuality, Male
  • Humans
  • Male
  • Middle Aged
  • Phylogeny
  • Quinolones / pharmacology
  • Shigella flexneri / classification
  • Shigella flexneri / drug effects*
  • Shigella flexneri / genetics*
  • Shigella flexneri / isolation & purification
  • Treatment Outcome
  • Whole Genome Sequencing
  • beta-Lactamases / genetics*

Substances

  • Anti-Bacterial Agents
  • Quinolones
  • Ceftriaxone
  • beta-Lactamases